Target intelligence / Profile preview

Muscle satellite cell (MuSC)

Target
MuSC
Molecular classification
Other
01

Overview

Muscle satellite cells (MuSCs) are the primary resident stem cells of skeletal muscle, located in a specialized niche between the basal lamina and the sarcolemma of muscle fibers (Mauro, 1961; PMID: 13768451). These cells are typically quiescent in adult muscle but become activated in response to mechanical strain or injury to proliferate and differentiate into myoblasts, which then fuse to form new myofibers or repair existing ones (Dumont et al., 2015; PMID: 26114479). This regenerative process is critical for maintaining muscle mass and function throughout the lifespan. In diseases such as Duchenne muscular dystrophy and age-related sarcopenia, the satellite cell population may become depleted or functionally impaired, contributing to progressive muscle loss (Sacco & Puri, 2015; PMID: 26461081). While not a single molecular target, MuSCs are the focus of various therapeutic interventions, including myostatin inhibitors and HDAC inhibitors like Givinostat, which aim to enhance their regenerative potential (Consalvi et al., 2014; PMID: 24510943). Consequently, they represent a vital cellular target for regenerative medicine and the treatment of neuromuscular disorders.

Other names
Satellite cellMyosatellite cellSkeletal muscle stem cell
02

Mechanism of action

Pharmacological agents modulate satellite cell activity by inhibiting negative regulators like myostatin or by altering the epigenetic landscape via HDAC inhibition to promote myogenic progression and muscle fiber repair (Consalvi et al., 2014; PMID: 24510943).

03

Biological functions

Cell proliferationCell differentiationMuscle regenerationMyogenesisSelf-renewal
04

Disease associations

Muscular dystrophySarcopeniaMuscle atrophyCachexiaMuscle injury
05

Safety considerations

Stem cell pool exhaustionRisk of oncogenic transformation (e.g., rhabdomyosarcoma)Off-target effects on non-muscle stem cell niches
06

Interacting drugs

Givinostat

4 more in the full profile.

07

Biomarkers

PAX7MYF5MYOD1CD34NCAM1 (CD56)

Beyond the preview

Go deeper on Muscle satellite cell (MuSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle satellite cell (MuSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call